Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study).
Trials. 2019 Apr 3;20(1):191. doi: 10.1186/s13063-019-3259-x.
Trials. 2019.
PMID: 30944040
Free PMC article.
Clinical Trial.